Immune System and Non-Infectious Diseases
The immune system plays a critical role in the development and progression of many non-infectious diseases, including cancer, autoimmune disorders, and allergies. In cancer, the immune system can recognize and eliminate abnormal cells, but tumors can evade immune surveillance through a variety of mechanisms. Immunotherapies that boost the immune response against cancer cells have shown remarkable success in clinical trials. Similarly, autoimmune disorders such as rheumatoid arthritis and multiple sclerosis are characterized by the immune system attacking healthy tissues. Treatments such as biologics and small molecule inhibitors that modulate the immune system have been developed to manage these diseases. The study of the immune system's role in non-infectious diseases represents a promising area for the development of new therapies.
Related Conference of Immune System and Non-Infectious Diseases
9th International Conference on Vaccines, Immunology and Clinical Trials
Immune System and Non-Infectious Diseases Conference Speakers
Recommended Sessions
- Clinical Trials: Safety, Efficacy, and Beyond
- Challenges in Global Vaccination Programs
- Cutting-Edge Techniques in Vaccine Manufacturing
- Gene Editing for Vaccine Development
- Immune System and Non-Infectious Diseases
- Immunology and Infectious Diseases: Current Landscape
- Immunology of Aging and Vaccination
- Immunotherapy: Novel Strategies and Technologies
- Innovative Approaches to Vaccine Design
- Next-Generation Vaccines: Advancements and Challenges
- Precision Medicine and Personalized Vaccines
- Public-Private Partnerships for Vaccine Research
- Regulatory Guidelines for Vaccine Approval
- The Future of Vaccinology: Trends and Prospects
- Vaccine Hesitancy: Causes and Solutions
Related Journals
Are you interested in
- Advancements in Vaccine Research and Development - Vaccines R&D 2026 (France)
- Advances in Pediatric Vaccines - Vaccines R&D 2026 (France)
- Antimicrobial Resistance (AMR) - VACCINES WORLD 2025 (Germany)
- Bioprocessing and Manufacturing - VACCINES WORLD 2025 (Germany)
- Cancer Vaccines and Immunotherapy - VACCINES WORLD 2025 (Germany)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2025 (France)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2025 (France)
- Clinical Trials - VACCINES WORLD 2025 (Germany)
- Clinical Trials Design and Methodologies - Vaccines R&D 2026 (France)
- Conjugate Vaccine - VACCINES WORLD 2025 (Germany)
- Coronavirus (COVID-19) & Pandemic Vaccines - VACCINES WORLD 2025 (Germany)
- DNA Vaccines - Euro Vaccines 2025 (France)
- DNA-RNA Vaccines - VACCINES WORLD 2025 (Germany)
- Emerging and Re-Emerging Diseases - VACCINES WORLD 2025 (Germany)
- Emerging Infectious Diseases and Vaccine Development - Vaccines R&D 2026 (France)
- Ethical Considerations in Vaccine Development and Distribution - Vaccines R&D 2026 (France)
- Fungal/Bacterial/Viral/Parasitic/STD Vaccines - VACCINES WORLD 2025 (Germany)
- Global Immunization Strategies and Policy - Vaccines R&D 2026 (France)
- Hepatitis Vaccines - Euro Vaccines 2025 (France)
- HIV Vaccines - VACCINES WORLD 2025 (Germany)
- HIV/AIDS Vaccines - Euro Vaccines 2025 (France)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2025 (France)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2025 (France)
- Immune Profiling - VACCINES WORLD 2025 (Germany)
- Immunology of Infectious Diseases - Vaccines R&D 2026 (France)
- Immunology/Animal Models - Euro Vaccines 2025 (France)
- Immunotherapy and Personalized Medicine - Vaccines R&D 2026 (France)
- Infectious and Non-Infectious Diseases - VACCINES WORLD 2025 (Germany)
- Influenza and Respiratory Vaccines - VACCINES WORLD 2025 (Germany)
- Innovations in Vaccine Cold Chain and Storage - Vaccines R&D 2026 (France)
- Mucosal Vaccines - Euro Vaccines 2025 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2025 (France)
- Regulatory Approaches in Vaccine Development - Vaccines R&D 2026 (France)
- Role of Adjuvants in Vaccine Efficacy - Vaccines R&D 2026 (France)
- Role of AI and Big Data in Vaccine Research - Vaccines R&D 2026 (France)
- Thermo Stabilized Vaccines - VACCINES WORLD 2025 (Germany)
- Translational Immunology and Vaccine Development - Vaccines R&D 2026 (France)
- Vaccine Adjuvants - Euro Vaccines 2025 (France)
- Vaccine Adjuvants - VACCINES WORLD 2025 (Germany)
- Vaccine Delivery Systems: Innovations and Challenges - Vaccines R&D 2026 (France)
- Vaccine Development for Cancer Immunotherapy - Vaccines R&D 2026 (France)
- Vaccine Development for Vector-Borne Diseases - Vaccines R&D 2026 (France)
- Vaccine Equity and Access in Low-Resource Settings - Vaccines R&D 2026 (France)
- Vaccine Hesitancy and Public Perception - Vaccines R&D 2026 (France)
- Vaccine Manufacturing and Distribution - Vaccines R&D 2026 (France)
- Vaccine Production, Supply & Logistics - VACCINES WORLD 2025 (Germany)
- Vaccine Research & Development - Euro Vaccines 2025 (France)
- Vaccine Research and Development - VACCINES WORLD 2025 (Germany)
- Vaccine Safety and Pharmacovigilance - Vaccines R&D 2026 (France)
- Vaccine Safety, Efficacy & Regulatory Affairs - VACCINES WORLD 2025 (Germany)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2025 (France)
- Vaccines Business Development - Euro Vaccines 2025 (France)
- Vaccines for Older Adults - Euro Vaccines 2025 (France)
- Vaccines for Respiratory Diseases - Euro Vaccines 2025 (France)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2025 (France)
- Vaccines Safety & Efficacy - Euro Vaccines 2025 (France)
- Veterinary Vaccine - VACCINES WORLD 2025 (Germany)
- Veterinary Vaccines - Euro Vaccines 2025 (France)